Bench-mark test for EndoBRAIN-02

ABSTRACT: Primary outcome(s): To assess whether EB-02’s performance exceeds a 90% specificity in diagnosing invasive cancer.

DISEASE(S): Colorectal Cancer

PROVIDER: 2652875 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR